GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kedoya Adyaraya Tbk PT RSGK.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

950

-2.06%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Kedoya Adyaraya Tbk PT

Its shares trade on IDX under the ticker RSGK.JK. It has been listed since 8 September 2021. In the fiscal year to 31 December 2025, it reported revenue of IDR 469.59bn and net income of IDR 34.51bn. At that date it held total assets of IDR 1.08trn and shareholders' equity of IDR 828.79bn.

PT Kedoya Adyaraya Tbk engages in healthcare services. The company is headquartered in Jakarta Barat, Dki Jakarta. The company went IPO on 2021-09-08. The firm provides a range of services, such as advanced medical rehabilitation, cardiovascular center, stroke center, and trauma center. The firm has introduced robotic assisted rehabilitation therapy tools called LEXO and DIEGO. Robotic Rehabilitation is be used for the recovery process in patients with the following medical indications, such as stroke, brain injury, spinal cord injury, multiple sclerosis, Parkinson's disease, and post cruciate ligament reconstruction. Its cardiovascular center provides integrated services ranging from screening, diagnostics, therapy, and rehabilitation. Its stroke center provides integrated and comprehensive services for handling all problems that arise in connection with stroke. Its trauma center provides various services, such as Emergency services, head trauma, face and dental trauma, and limb trauma.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
8 Sept 2021
Employees
706

Leadership

Pay as last reported

  • Mr. Jusup HalimiPresident Commissioner
  • Dr. Liem Kian HongPresident Director
  • Mr. Armen Antonius DjanDirector
  • Dr. Juniwati GunawanDirector
  • Mr. Hendra MunantoDirector, since 2018
  • Mr. Willy ..Corporate Secretary, Head - Legal
  • Mr. Hungkang SutedjaCommissioner, since 2009
  • Mr. Murniadi ChandraIndependent Commissioner
  • Dr. Yanto Sandy TjangIndependent Commissioner

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company provides advanced medical rehabilitation services including robotic assisted therapy tools LEXO and DIEGO.
  • Offers integrated services in cardiovascular, stroke, and trauma centers.
  • Has a range of specialized medical services for conditions like stroke and spinal cord injury.

Weaknesses

  • Company is a relatively new IPO from 2021-09-08 with limited historical data.
  • No information provided on financial performance or market share.
  • Limited details on the scale of operations beyond employee count and service types.

Opportunities

  • Expansion of robotic rehabilitation tools to new medical indications and markets.
  • Growth potential in integrated healthcare services for chronic conditions.
  • Potential for increased market share in Jakarta's healthcare sector.

Threats

  • Competition from other healthcare providers in Jakarta.
  • Dependence on specific medical indications for robotic therapy tools.
  • Regulatory challenges in healthcare service delivery.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.